Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
J Pharm Negat
Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK clinical practice research datalink[J]
In the head-to-head SURMOUNT-5 trial (NEJM 2025), tirzepatide produced 20.2% weight loss vs 13.7% for semaglutide
Kellys special talent for integrating information from many sources and finding practical solutions has made her a popular speaker and workshop leader
US$ 27.55
US$ 20.54
US$ 21.21
US$ 22.89
US$ 28.41
US$ 20.56
US$ 27.70
US$ 26.92
